| Primary |
| Product Used For Unknown Indication |
82.4% |
| Gastroenteritis |
17.6% |
|
| Gingival Bleeding |
16.7% |
| Persecutory Delusion |
16.7% |
| Prescribed Overdose |
16.7% |
| Urticaria |
16.7% |
| Vomiting |
16.7% |
| White Blood Cell Count Decreased |
16.7% |
|
| Secondary |
| Product Used For Unknown Indication |
27.1% |
| Drug Use For Unknown Indication |
19.4% |
| Pain |
9.4% |
| Pyrexia |
6.8% |
| Hypertension |
4.3% |
| Influenza |
4.3% |
| Bronchitis |
4.2% |
| Neck Pain |
2.7% |
| Toothache |
2.5% |
| Prophylaxis |
2.3% |
| Tonsillitis |
2.0% |
| Cholelithiasis |
1.9% |
| Headache |
1.7% |
| Infection |
1.7% |
| Cholecystectomy |
1.7% |
| Hypercholesterolaemia |
1.7% |
| Anxiety |
1.6% |
| Back Pain |
1.6% |
| Suicide Attempt |
1.6% |
| Arthralgia |
1.5% |
|
| Thrombocytopenia |
12.2% |
| Vomiting |
11.7% |
| Hepatitis |
5.6% |
| Neutropenia |
5.6% |
| Pruritus |
5.6% |
| Agranulocytosis |
5.1% |
| Cytolytic Hepatitis |
5.1% |
| Urticaria |
5.1% |
| Colitis Ischaemic |
4.1% |
| Hepatocellular Injury |
4.1% |
| Respiratory Disorder |
4.1% |
| Stevens-johnson Syndrome |
4.1% |
| Toxic Skin Eruption |
4.1% |
| Transaminases Increased |
4.1% |
| Rash Maculo-papular |
3.6% |
| Renal Failure Acute |
3.6% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
3.1% |
| Haematoma |
3.1% |
| Hepatic Fibrosis |
3.1% |
| Jaundice |
3.1% |
|
| Concomitant |
| Drug Use For Unknown Indication |
33.2% |
| Product Used For Unknown Indication |
18.7% |
| Pain |
7.8% |
| Hypertension |
6.6% |
| Rheumatoid Arthritis |
4.4% |
| Prophylaxis |
3.0% |
| Hepatitis C |
2.8% |
| Depression |
2.6% |
| Pyrexia |
2.6% |
| Back Pain |
2.3% |
| Hiv Infection |
2.0% |
| Anxiety |
2.0% |
| Bronchitis |
1.8% |
| Unevaluable Event |
1.8% |
| Thrombosis Prophylaxis |
1.7% |
| Crohn's Disease |
1.6% |
| Osteoporosis |
1.5% |
| Premedication |
1.3% |
| Urinary Tract Infection |
1.3% |
| Diabetes Mellitus |
1.3% |
|
| Thrombocytopenia |
11.3% |
| Vomiting |
10.9% |
| Renal Failure Acute |
10.2% |
| Renal Failure |
6.7% |
| Weight Decreased |
6.2% |
| Toxic Skin Eruption |
5.8% |
| Somnolence |
5.3% |
| Pyrexia |
5.1% |
| Malaise |
4.4% |
| Neutropenia |
4.0% |
| Pulmonary Embolism |
3.4% |
| Rash |
3.3% |
| Urticaria |
3.3% |
| Stevens-johnson Syndrome |
3.1% |
| Cytolytic Hepatitis |
2.9% |
| Hyponatraemia |
2.9% |
| Transaminases Increased |
2.9% |
| Vertigo |
2.9% |
| Vision Blurred |
2.9% |
| Hepatocellular Injury |
2.7% |
|
| Interacting |
| Bone Pain |
13.8% |
| Pain |
13.8% |
| Drug Use For Unknown Indication |
10.3% |
| Product Used For Unknown Indication |
10.3% |
| Hypercholesterolaemia |
6.9% |
| Hypertension |
6.9% |
| Infection |
6.9% |
| Migraine |
6.9% |
| Psoriatic Arthropathy |
6.9% |
| Aortic Valve Replacement |
3.4% |
| Arrhythmia |
3.4% |
| Atrial Fibrillation |
3.4% |
| Erysipelas |
3.4% |
| Ventricular Arrhythmia |
3.4% |
|
| International Normalised Ratio Increased |
44.4% |
| Erysipelas |
11.1% |
| Muscle Haemorrhage |
11.1% |
| Pneumonia Aspiration |
11.1% |
| Rhabdomyolysis |
11.1% |
| Transaminases Increased |
11.1% |
|
